Accuray to Report Second Quarter Fiscal 2022 Financial Results on January 26, 2022
The conference call dial-in numbers are (833) 316-0563 (
A live webcast of the call will also be available from the Investor Relations section of the Company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the third quarter of fiscal 2022.
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale,
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
Public Relations Director,
+1 (408) 789-4426